Global Thin Film Drug Manufacturing Market: Snapshot

The thin film drugs were recorded with high market acceptance due to its ease of application and high effectiveness. Moreover, developed economies such as the U.S. and countries in Europe recorded significant sale of thin film drugs. Thin film drugs achieve the desired therapeutic results. Therefore, they have gained attention in the market as a potential treatment option. According to the research report, the global thin film drug manufacturing market is expected to be worth US$15,984.3 mn by the end of 2024 from US$7,337.8 mn in 2015. During the forecast years of 2016 and 2024, the global market is projected to exhibit a CAGR of 9.0%.

Demand for thin film drugs is increasing globally, leading to considerable research and development activities in the segment. The Journal of Controlled Release 2015 stated the market for oral thin film products exists with around 10 prescription products and around 29 such thin film products under clinical trials. Thus, the thin film drug manufacturing market is anticipated to expand considerably during the forecast period.

thin film drug manufacturing market

 

Oral Thin Films to Remain Popular due to Ease of Handling

On the basis of product type, the global thin film drug manufacturing market is segmented into oral thin film, transdermal thin film, and others such as ocular thin film among others. The report indicates that the oral thin film segment will be the most promising one as it comes with maximum advantages. These films deliver drugs through the oral mucosa and are known for ease of transportation, skipping the hepatic first pass effect, convenience of handling, and quick onset of action. In light of these benefits, the oral thin film segment is likely to surge at a significant CAGR of 18.3% between 2016 and 2024. Soaring revenue of this segment is attributable to the growing number of clinical trials and higher number of prescription products. On the other hand, the transdermal thin film segment is also poised to emerge with a substantial share in the global market by the end of the forecast period.

North America Emerges as Leading Regional Market

By geography, global thin film drug manufacturing market has been segmented into North America, Europe, Asia Pacific, Latin America, the and Middle East and Africa. In 2016, North America and Europe accounted for the largest share of the thin film drug manufacturing market. The U.S. dominated the thin film drug manufacturing market in North America, accounting for around 85.3% share in 2016. This dominance is majorly due factors such technological advancements in pharmaceutical research with rising demand of novel drug delivery. The extensive investments in research and development are also likely to benefit the regional market. However, Europe is saturated and growing at slow steady rate while Asia Pacific is anticipated to witness the fast growth during the forecast period with major contribution of countries such as India, Japan and China. New product launches with broaden applications, favorable regulations, and growing awareness are likely to drive the market in Asia Pacific during the forecast period.

Some of the key players in the global thin film drug manufacturing market are Pfizer, Inc., Novartis AG, Wolters Kluwer, Solvay, Allergan plc. Sumitomo Dainippon Pharma Co., Ltd., IntelGenx Corp. The global thin film drug manufacturing market is dominated only by few players, which makes the competitive landscape highly consolidated.

Global Thin Film Drug Manufacturing Market: Overview

This report on thin film drug manufacturing market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing services of thin film drug manufacturing products such as oral thin film, transdermal thin film and others as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global thin film drug manufacturing market with respect to the leading market segments based on major disease indication segment, products segment, distribution channels, and geographies.

Global Thin Film Drug Manufacturing Market: Segmentation

Based on the product type, the thin film drug manufacturing market has been segmented into: oral thin film, transdermal thin film and others. Each of the market segments have been extensively analyzed based on the market related factors such as increasing demand of thin film drug manufacturing products worldwide, and technological advancement. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2014 to 2024. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2016 to 2024, considering 2015 as the base year.

Global Thin Film Drug Manufacturing Market: Drivers and Trends

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the thin film drug manufacturing market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global thin film drug manufacturing market.

Global Thin Film Drug Manufacturing Market: Regional Outlook

Geographically, thin film drug manufacturing market has been segmented into five major regions: North America, Europe, Asia, Latin America, and Middle East and Africa. The market size and forecast for each of these regions has been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter’s five forces analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global thin film drug manufacturing market.

Key Players Mentioned in this Report are:

The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global thin film drug manufacturing market. The report also profiles key players operating in the thin film drug manufacturing market which are Pfizer, Inc., Novartis AG, Allergan plc, Wolters Kluwer, Solvay, IntelGenx Corp., Sumitomo Dainippon Pharma Co., Ltd., Indivior plc and ZIM Laboratories Limited

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

The global thin film drug manufacturing market is segmented as follows:

by Product Type

  • Oral Thin Film
    • Sublingual Film
    • Fully Dissolving Dental/Buccal Film
  • Transdermal Thin Film
  • Others (ocular thin film, etc.)

by Disease Indication

  • Schizophrenia
  • Migraine
  • Opioid Dependence
  • Nausea & Vomiting
  • Others

by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of the Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arebia
    • UAE
    • Rest of MEA

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

1. Preface 
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology 

3. Executive Summary

4. Market Overview
     4.1. Introduction
            4.1.1. Product Definition
            4.1.2. Industry Evolution / Developments
     4.2. Overview
     4.3. Key Market Indicators
     4.4. Market Dynamics
            4.4.1. Drivers
            4.4.2. Restraints
            4.4.3. Opportunity 
     4.5. Global Thin Film Drug Manufacturing  Analysis and Forecasts, 2016–2024
     4.6. Thin Film Drug Manufacturing  - Global Supply Demand Scenario
     4.7. Porter’s Five Force Analysis
     4.8. Value Chain Analysis
     4.9. Market Outlook

5.  Global Thin Film Drug Manufacturing  Analysis and Forecasts, By Product
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Key Trends
     5.4. Market Value Forecast By Product, 2016–2024
            5.4.1. Oral Thin Film
                     5.4.1.1. Sublingual film
                     5.4.1.2. Fully dissolving dental/ buccal film
            5.4.2. Transdermal Thin Film
            5.4.3. Others
     5.5. Product  Comparison Matrix
     5.6. Market Attractiveness By Product
     5.7. Oral Thin Film Drugs : Key market insights
            5.7.1. Pipeline Analysis
            5.7.2. Technology Insights
            5.7.3. Key Product Insights

6. Global Thin Film Drug Manufacturing  Analysis and Forecasts, By Distribution Channel
     6.1. Introduction & Definition
     6.2. Key Findings
     6.3. Market Value Forecast By Distribution Channel, 2016–2024
            6.3.1. Hospital Pharmacies
            6.3.2.  Drug Stores
            6.3.3. Retail Pharmacies
            6.3.4. E- Commerce
     6.4. Distribution Channel  Comparison Matrix
     6.5. Market Attractiveness By Distribution Channel 

7. Global Thin Film Drug Manufacturing  Analysis and Forecasts, By Disease Indication
     7.1. Introduction & Definition
     7.2. Key Findings
     7.3. Key Trends
     7.4. Market Value Forecast By Disease Indication, 2016–2024
            7.4.1. Schizophrenia
            7.4.2. Migraine
            7.4.3. Opioid Dependence
            7.4.4. Nausea & Vomiting
            7.4.5. Others
     7.5. Disease Indication Comparison Matrix
     7.6. Market Attractiveness By Disease Indication

8. Global Thin Film Drug Manufacturing  Analysis and Forecasts, By Region
     8.1. Introduction & Definition
     8.2. Key Findings
     8.3. Market Value Forecast By Region
            8.3.1. North America
            8.3.2. Latin America 
            8.3.3. Asia Pacific
            8.3.4. Europe
            8.3.5. Middle East & Africa
     8.4. Market Attractiveness By Country/Region

9. North America Thin Film Drug Manufacturing  Analysis and Forecast
     9.1. Introduction
     9.2. Market Value Forecast By Product, 2016–2024
            9.2.1. Oral Thin Film
                     9.2.1.1. Sublingual film
                     9.2.1.2. Fully dissolving dental/ buccal film
            9.2.2. Transdermal Thin Film
            9.2.3. Others (Ocular Thin Film, etc.)
     9.3. Market Value Forecast By Distribution Channel, 2016–2024
            9.3.1. Hospital Pharmacies
            9.3.2. Drug Stores
            9.3.3. Retail Pharmacies
            9.3.4. E- Commerce
     9.4. Market Value Forecast By Disease Indication, 2016–2024
            9.4.1. Schizophrenia
            9.4.2. Migraine
            9.4.3. Opioid Dependence
            9.4.4. Nausea & Vomiting
            9.4.5. Others
     9.5. Market Value Forecast By Country, 2016–2024
            9.5.1. U.S.
            9.5.2. Canada
     9.6. Market Attractiveness Analysis 
            9.6.1. By Product
            9.6.2. By Distribution Channel
            9.6.3. By Disease Indication
            9.6.4. By Country

10. Latin America Thin Film Drug Manufacturing  Analysis and Forecast
     10.1. Introduction
     10.2. Market Value Forecast By Product, 2016–2024
            10.2.1. Oral Thin Film
                     10.2.1.1. Sublingual film
                     10.2.1.2. Fully dissolving dental/ buccal film
            10.2.2. Transdermal Thin Film
            10.2.3. Others (Ocular Thin Film, etc.)
     10.3. Market Value Forecast By Distribution Channel, 2016–2024
            10.3.1. Hospital Pharmacies
            10.3.2. Drug Stores
            10.3.3. Retail Pharmacies
            10.3.4. E- Commerce
     10.4. Market Value Forecast By Disease Indication, 2016–2024
            10.4.1. Schizophrenia
            10.4.2. Migraine
            10.4.3. Opioid Dependence
            10.4.4. Nausea & Vomiting
            10.4.5. Others
     10.5. Market Value Forecast By Country, 2016–2024
            10.5.1. Brazil
            10.5.2. Mexico
            10.5.3. Rest of Latin America
     10.6. Market Attractiveness Analysis 
            10.6.1. By Product
            10.6.2. By Distribution Channel
            10.6.3. By Disease Indication
            10.6.4. By Country

11. Asia Pacific Thin Film Drug Manufacturing  Analysis and Forecast
     11.1. Introduction
     11.2. Market Value Forecast By Product, 2016–2024
            11.2.1. Oral Thin Film
                     11.2.1.1. Sublingual film
                     11.2.1.2. Fully dissolving dental/ buccal film
            11.2.2. Transdermal Thin Film
            11.2.3. Others (Ocular Thin Film, etc.)
     11.3. Market Value Forecast By Distribution Channel, 2016–2024
            11.3.1. Hospital Pharmacies
            11.3.2. Drug Stores
            11.3.3. Retail Pharmacies
            11.3.4. E- Commerce
     11.4. Market Value Forecast By Disease Indication, 2016–2024
            11.4.1. Schizophrenia
            11.4.2. Migraine
            11.4.3. Opioid Dependence
            11.4.4. Nausea & Vomiting
            11.4.5. Others
     11.5. Market Value Forecast By Country, 2016–2024
            11.5.1. Japan
            11.5.2. India
            11.5.3. China
            11.5.4. Rest Of Asia Pacific
     11.6. Market Attractiveness Analysis 
            11.6.1. By Product
            11.6.2. By Distribution Channel
            11.6.3. By Disease Indication
            11.6.4. By Country

12.  Europe Thin Film Drug Manufacturing  Analysis and Forecast
     12.1. Introduction
     12.2. Market Value Forecast By Product, 2016–2024
            12.2.1. Oral Thin Film
                     12.2.1.1. Sublingual film
                     12.2.1.2. Fully dissolving dental/ buccal film
            12.2.2. Transdermal Thin Film
            12.2.3. Others (Ocular Thin Film, etc.)
     12.3. Market Value Forecast By Distribution Channel, 2016–2024
            12.3.1. Hospital Pharmacies
            12.3.2. Drug Stores
            12.3.3. Retail Pharmacies
            12.3.4. E- Commerce
     12.4. Market Value Forecast By Disease Indication, 2016–2024
            12.4.1. Schizophrenia
            12.4.2. Migraine
            12.4.3. Opioid Dependence
            12.4.4. Nausea & Vomiting
            12.4.5. Others
     12.5. Market Value Forecast By Country, 2016–2024
            12.5.1. France
            12.5.2. Germany 
            12.5.3. Italy
            12.5.4. Spain
            12.5.5. Russia
            12.5.6. Rest Of Europe
     12.6. Market Attractiveness Analysis 
            12.6.1. By Product
            12.6.2. By Distribution Channel
            12.6.3. By Disease Indication
            12.6.4. By Country

13. Middle East & Africa Thin Film Drug Manufacturing  Analysis and Forecast
     13.1.  Introduction
     13.2. Market Value Forecast By Product, 2016–2024
            13.2.1. Oral Thin Film
                     13.2.1.1. Sublingual film
                     13.2.1.2. Fully dissolving dental/ buccal film
            13.2.2. Transdermal Thin Film
            13.2.3. Others (Ocular Thin Film, etc.)
     13.3. Market Value Forecast By Distribution Channel, 2016–2024
            13.3.1. Hospital Pharmacies
            13.3.2. Drug Stores
            13.3.3. Retail Pharmacies
            13.3.4. E- Commerce
     13.4. Market Value Forecast By Disease Indication, 2016–2024
            13.4.1. Schizophrenia
            13.4.2. Migraine
            13.4.3. Opioid Dependence
            13.4.4. Nausea & Vomiting
            13.4.5. Others
     13.5. Market Value Forecast By Country, 2016–2024
            13.5.1. South Africa
            13.5.2. Saudi Arabia
            13.5.3. UAE
            13.5.4. Rest of Middle East & Africa
     13.6. Market Attractiveness Analysis 
            13.6.1. By Product
            13.6.2. By Distribution Channel
            13.6.3. By Disease Indication
            13.6.4. By Country

14. Competition Landscape
     14.1. Market Player – Competition Matrix (By Tier and Size of companies)
     14.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
            14.2.1. ZIM Laboratories Limited
                     14.2.1.1. Company Details
                     14.2.1.2. Business Overview
                     14.2.1.3. Financial Overview
                     14.2.1.4. Strategic Overview
                     14.2.1.5. SWOT Analysis
            14.2.2. Indivior plc.
                     14.2.2.1. Company Details
                     14.2.2.2. Business Overview
                     14.2.2.3. Financial Overview
                     14.2.2.4. Strategic Overview
                     14.2.2.5. SWOT Analysis
            14.2.3. MonoSol Rx Allergan plc.
                     14.2.3.1. Company Details
                     14.2.3.2. Business Overview
                     14.2.3.3. Financial Overview
                     14.2.3.4. Strategic Overview
                     14.2.3.5. SWOT Analysis
            14.2.4. Sumitomo Dainippon Pharma Co., Ltd.
                     14.2.4.1. Company Details
                     14.2.4.2. Business Overview
                     14.2.4.3. Financial Overview
                     14.2.4.4. Strategic Overview
                     14.2.4.5. SWOT Analysis
            14.2.5. IntelGenx Corp
                     14.2.5.1. Company Details
                     14.2.5.2. Business Overview
                     14.2.5.3. Financial Overview
                     14.2.5.4. Strategic Overview
                     14.2.5.5. SWOT Analysis
            14.2.6. Pfizer, Inc.
                     14.2.6.1. Company Details
                     14.2.6.2. Business Overview
                     14.2.6.3. Financial Overview
                     14.2.6.4. Strategic Overview
                     14.2.6.5. SWOT Analysis
            14.2.7. Novartis AG
                     14.2.7.1. Company Details
                     14.2.7.2. Business Overview
                     14.2.7.3. Financial Overview
                     14.2.7.4. Strategic Overview
                     14.2.7.5. SWOT Analysis
            14.2.8. Allergan plc.
                     14.2.8.1. Company Details
                     14.2.8.2. Business Overview
                     14.2.8.3. Financial Overview
                     14.2.8.4. Strategic Overview
                     14.2.8.5. SWOT Analysis
            14.2.9. NAL Pharma
                     14.2.9.1. Company Details
                     14.2.9.2. Business Overview
                     14.2.9.3. Financial Overview
                     14.2.9.4. Strategic Overview
                     14.2.9.5. SWOT Analysis
            14.2.10. Wolters Kluwer
                     14.2.10.1. Company Details
                     14.2.10.2. Business Overview
                     14.2.10.3. Financial Overview
                     14.2.10.4. Strategic Overview
                     14.2.10.5. SWOT Analysis
            14.2.11. Solvay
                     14.2.11.1. Company Details
                     14.2.11.2. Business Overview
                     14.2.11.3. Financial Overview
                     14.2.11.4. Strategic Overview
                     14.2.11.5. SWOT Analysis

List of Tables

Table 01: Global Opportunity for Oral Thin Film Drugs Market (Addressable Market), Revenue (US$ Bn), Forecast 2016–2024, by Product Type
Table 02: Global Opportunity for Oral Thin Film Drugs Market (Addressable Market), Revenue (US$ Bn), Forecast 2016-2024, by Region
Table 03: Global Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type,2014–2024
Table 04: Global Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type,2014–2024
Table 05: Global Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Disease Indication, 2014–2024
Table 06: Global Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 07: Global Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Region, 2014–2024
Table 08: North America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 09: North America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 10: North America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type – Oral Thin Film, 2014–2024
Table 11: North America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Disease Indication, 2014–2024
Table 12: North America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 13: Latin America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 14: Latin America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 15: Latin America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type – Oral Thin Film, 2014–2024
Table 16: Latin America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Disease Indication, 2014–2024
Table 17: Latin America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 18: Asia Pacific Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 19: Asia Pacific Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 20: Asia Pacific Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 21: Asia Pacific Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Disease Indication, 2014–2024
Table 22: Asia Pacific Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 23: Europe Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 24: Europe Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 25: Europe Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 26: Europe Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Disease Indication, 2014–2024
Table 27: Europe Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 28: Middle East & Africa Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 29: Middle East & Africa Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 30: Middle East & Africa Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type – Oral Thin Film, 2014–2024
Table 31: Middle East & Africa Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Disease Indication, 2014–2024
Table 32: Middle East & Africa Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Distribution Channel

List of Figures

Figure 01: Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, 2016–2024
Figure 03: Market Value Share (%), by Disease Indication (2015)
Figure 05: Market Value Share (%), by Region (2015)
Figure 02: Market Value Share (%), by Product Type (2015)
Figure 04: Market Value Share (%), by Distribution Channel (2015)
Figure 06: Global Thin Film Drug Manufacturing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 07: Global Oral Thin Film Drug Market Revenue (US$ Mn), 2014–2024
Figure 08: Global Transdermal Thin Film Drug Market Revenue (US$ Mn), 2014–2024
Figure 09: Global others (ocular thin film, etc.) Market Revenue (US$ Mn), 2014–2024
Figure 10: Thin Film Drug Manufacturing Market Attractiveness Analysis, by Product Type, 2014–2024
Figure 11: Oral Thin Film Drug Manufacturing Market, Pipeline Analysis 2015
Figure 12: Oral Thin Film Drug Manufacturing Market, by Technology
Figure 13: Global Sales of Major OTF Products (US$ Thousand), 2014
Figure 14: Total SUBOXONE Film Sales (US$ Mn), 2010–2014
Figure 15: Total Onsolis & Breakyl Sales (US$ Thousand), 2011–2014
Figure 16: Total Fentanyl Product Sales (US$ Mn), 2010–2014
Figure 17: Global Thin Film Drug Manufacturing Market Value Share Analysis, by Disease Indication, 2016 and 2024
Figure 18: Global Thin Film Drug Manufacturing Market Revenue (US$ Mn) Forecast, by Schizophrenia, 2014–2024
Figure 19: Global Thin Film Drug Manufacturing Market Revenue (US$ Mn) Forecast, by Migraine, 2014–2024
Figure 20: Global Thin Film Drug Manufacturing Market Revenue (US$ Mn) Forecast, by Opioid Dependence, 2014–2024
Figure 21: Global Thin Film Drug Manufacturing Market Revenue (US$ Mn) Forecast, by Nausea & Vomiting, 2014–2024
Figure 22: Global Thin Film Drug Manufacturing Market Revenue (US$ Mn) Forecast, by Others, 2014–2024
Figure 23: Global Thin Film Drug Manufacturing Market Attractiveness Analysis, by Disease Indication, 2016-2024
Figure 24: Number of oral thin ?lm drugs by disease indication (out of total identified drugs at different drug development stages), 2015
Figure 25: Global Thin Film Drug Manufacturing Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 26: Thin Film Drug Manufacturing Market, by Hospital Pharmacies, Revenue (US$ Mn), 2014–2024
Figure 27: Thin Film Drug Manufacturing Market, by Drug Store, Revenue (US$ Mn), 2014–2024
Figure 28: Thin Film Drug Manufacturing Market, by Retail Pharmacies, Revenue (US$ Mn), 2014–2024
Figure 29: Thin Film Drug Manufacturing Market by E-Commerce, Revenue (US$ Mn), 2014–2024
Figure 30: Thin Film Drug Manufacturing Market Attractiveness Analysis, by Distribution Channel, 2014–2024
Figure 31: Global Thin Film Drug Manufacturing Market Value Share Analysis, by Region, 2016 and 2024
Figure 32: North America Thin Film Drug Manufacturing Market Revenue (US$ Mn), 2014–2024
Figure 33: Europe Thin Film Drug Manufacturing Market Revenue (US$ Mn), 2014–2024
Figure 34: Latin America Thin Film Drug Manufacturing Market Revenue (US$ Mn), 2014–2024
Figure 35: Asia Pacific Thin Film Drug Manufacturing Market Revenue (US$ Mn), 2014–2024
Figure 36: Middle East & Africa Thin Film Drug Manufacturing Market Revenue (US$ Mn), 2014–2024
Figure 37: Thin Film Drug Manufacturing Market Attractiveness Analysis, by Region, 2014–2024
Figure 38: North America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, 2014–2024
Figure 39: North America Thin Film Drug Manufacturing Market Attractiveness Analysis, by Country, 2016–2024
Figure 40: North America Thin Film Drug Manufacturing Market Value Share Analysis, by Country, 2016 and 2024
Figure 41: North America Thin Film Drug Manufacturing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 42: North America Thin Film Drug Manufacturing Market Value Share Analysis, by Disease Indication, 2016 and 2024
Figure 43: North America Thin Film Drug Manufacturing Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 44: North America Thin Film Drug Manufacturing Market Attractiveness Analysis, by Product Type, 2016–2024
Figure 45: North America Thin Film Drug Manufacturing Market Attractiveness Analysis, by Disease Indication, 2016–2024
Figure 46: North America Thin Film Drug Manufacturing Market Attractiveness Analysis, by Distribution Channel, 2016–2024
Figure 47: Latin America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, 2014–2024
Figure 48: Latin America Thin Film Drug Manufacturing Market Attractiveness Analysis, by Country, 2016–2024
Figure 49: Latin America Thin Film Drug Manufacturing Market Value Share Analysis, by Country, 2016 and 2024
Figure 50: Latin America Thin Film Drug Manufacturing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 51: Latin America Thin Film Drug Manufacturing Market Value Share Analysis, by Disease Indication, 2016 and 2024
Figure 52: Latin America Thin Film Drug Manufacturing Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 53: Latin America Thin Film Drug Manufacturing Market Attractiveness Analysis, by Product Type, 2016–2024
Figure 54: Latin America Thin Film Drug Manufacturing Market Attractiveness Analysis, by Disease Indication, 2016–2024
Figure 55: Latin America Thin Film Drug Manufacturing Market Attractiveness Analysis, by Distribution Channel, 2016–2024
Figure 56: Asia Pacific Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, 2014–2024
Figure 57: Asia Pacific Thin Film Drug Manufacturing Market Attractiveness Analysis, by Country, 2016–2024
Figure 58: Asia Pacific Thin Film Drug Manufacturing Market Value Share Analysis, by Country, 2016 and 2024
Figure 59: Asia Pacific Thin Film Drug Manufacturing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 60: Asia Pacific Thin Film Drug Manufacturing Market Value Share Analysis, by Disease Indication, 2016 and 2024
Figure 61: Asia Pacific Thin Film Drug Manufacturing Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 62: Asia Pacific Thin Film Drug Manufacturing Market Attractiveness Analysis, by Product Type, 2016–2024
Figure 63: Asia Pacific Thin Film Drug Manufacturing Market Attractiveness Analysis, by Disease Indication, 2016–2024
Figure 64: Asia Pacific Thin Film Drug Manufacturing Market Attractiveness Analysis, by Distribution Channel, 2016–2024
Figure 65: Europe Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, 2014–2024
Figure 66: Europe Thin Film Drug Manufacturing Market Attractiveness Analysis, by Country, 2016–2024
Figure 67: Europe Thin Film Drug Manufacturing Market Value Share Analysis, by Country, 2016 and 2024
Figure 68: Europe Thin Film Drug Manufacturing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 69: Europe Thin Film Drug Manufacturing Market Value Share Analysis, by Disease Indication, 2016 and 2024
Figure 70: Europe Thin Film Drug Manufacturing Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 71: Europe Thin Film Drug Manufacturing Market Attractiveness Analysis, by Product Type, 2016–2024
Figure 72: Europe Thin Film Drug Manufacturing Market Attractiveness Analysis, by Disease Indication, 2016–2024
Figure 73: Europe Thin Film Drug Manufacturing Market Attractiveness Analysis, by Distribution Channel, 2016–2024
Figure 74: Middle East & Africa Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, 2014–2024
Figure 75: Middle East & Africa Thin Film Drug Manufacturing Market Attractiveness Analysis, by Country, 2016–2024
Figure 76: Middle East & Africa Thin Film Drug Manufacturing Market Value Share Analysis, by Country, 2016 and 2024
Figure 77: Middle East & Africa Thin Film Drug Manufacturing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 78: Middle East & Africa Thin Film Drug Manufacturing Market Value Share Analysis, by Disease Indication, 2016 and 2024
Figure 79: Middle East & Africa Thin Film Drug Manufacturing Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 80: Middle East & Africa Thin Film Drug Manufacturing Market Attractiveness Analysis, by Product Type, 2016–2024
Figure 81: Middle East & Africa Thin Film Drug Manufacturing Market Attractiveness Analysis, by Disease Indication, 2016–2024
Figure 82: Middle East & Africa Thin Film Drug Manufacturing Market Attractiveness Analysis, by Distribution Channel, 2016–2024

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Thin Film Drug Manufacturing Market